LBSAT229 Extended-release Calcifediol Effectively Raised 25-hydroxyvitamin D In CKD Despite Obesity

por Strugnell, Stephen A, Ashfaq, Akhtar, Bishop, Charles W
Publicado 2022

Evaluation of Therapies for Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Chronic Kidney Disease

por Strugnell, Stephen A., Csomor, Philipp, Ashfaq, Akhtar, Bishop, Charles W.
Publicado 2023

LBSAT230 Daily Variation In Serum Calcifediol In Japanese And Non-japanese Adults

por Ashfaq, Akhtar, Strugnell, Stephen A, Tabash, Samir, Bishop, Charles W
Publicado 2022

Extended-Release Calcifediol Effectively Raises Serum Total 25-Hydroxyvitamin D Even in Overweight Nondialysis Chronic Kidney Disease Patients with Secondary Hyperparathyroidism

por Bishop, Charles W., Strugnell, Stephen A., Csomor, Philipp, Kaiser, Edelgard, Ashfaq, Akhtar
Publicado 2022

REsCue trial: Randomized controlled clinical trial with extended-release calcifediol in symptomatic COVID-19 outpatients

por Bishop, Charles W., Ashfaq, Akhtar, Melnick, Joel Z., Vazquez-Escarpanter, Enrique, Fialkow, Jonathan A., Strugnell, Stephen A., Choe, John, Kalantar-Zadeh, Kamyar, Federman, Noah C., Ng, David, Adams, John S.
Publicado 2023